Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| COMPASS Pathways plc | 152,002 | reported | 26 Mar 2026 | tx 9+513,996−10,716 |
| SQZ Biotechnologies Co | 75,950 | reported | 23 Feb 2021 | tx 2+86,480 |
| Vaxcyte, Inc. | 10,216 | reported | 12 Jun 2025 | tx 25+109,088−25,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Mar 2026 | GRANT_AWARD | COMPASS Pathways plc | 75,000 | 0.00 USD | |
| 26 Mar 2026 | GRANT_AWARD | COMPASS Pathways plc | 157,635 | 0.00 USD | deriv |
| 11 Mar 2026 | TAX_WITHHOLDING | COMPASS Pathways plc | 1,781 | 6.89 USD | |
| 02 Mar 2026 | TAX_WITHHOLDING | COMPASS Pathways plc | 4,467 | 7.02 USD | |
| 12 Jun 2025 | GRANT_AWARD | Vaxcyte, Inc. | 3,041 | 0.00 USD | |
| 12 Jun 2025 | GRANT_AWARD | Vaxcyte, Inc. | 15,372 | 0.00 USD | deriv |
| 11 Mar 2025 | GRANT_AWARD | COMPASS Pathways plc | 25,000 | 0.00 USD | |
| 11 Mar 2025 | GRANT_AWARD | COMPASS Pathways plc | 76,000 | 0.00 USD | deriv |
| 03 Mar 2025 | TAX_WITHHOLDING | COMPASS Pathways plc | 4,468 | 3.67 USD | |
| 15 Jan 2025 | SALE | Vaxcyte, Inc. | 1,043 | 85.29 USD | |
| 15 Jan 2025 | SALE | Vaxcyte, Inc. | 966 | 86.26 USD | |
| 15 Jan 2025 | EXERCISE | Vaxcyte, Inc. | 6,250 | 22.70 USD | |
| 15 Jan 2025 | SALE | Vaxcyte, Inc. | 1,013 | 87.38 USD | |
| 15 Jan 2025 | SALE | Vaxcyte, Inc. | 529 | 88.54 USD | |
| 15 Jan 2025 | SALE | Vaxcyte, Inc. | 146 | 80.46 USD | |
| 15 Jan 2025 | SALE | Vaxcyte, Inc. | 215 | 81.53 USD | |
| 15 Jan 2025 | SALE | Vaxcyte, Inc. | 1,136 | 82.89 USD | |
| 15 Jan 2025 | SALE | Vaxcyte, Inc. | 1,202 | 83.93 USD | |
| 15 Jan 2025 | EXERCISE | Vaxcyte, Inc. | 6,250 | 0.00 USD | deriv |
| 17 Sept 2024 | SALE | Vaxcyte, Inc. | 241 | 114.64 USD | |
| 17 Sept 2024 | EXERCISE | Vaxcyte, Inc. | 6,250 | 22.70 USD | |
| 17 Sept 2024 | SALE | Vaxcyte, Inc. | 256 | 117.51 USD | |
| 17 Sept 2024 | SALE | Vaxcyte, Inc. | 1,445 | 115.32 USD | |
| 17 Sept 2024 | SALE | Vaxcyte, Inc. | 4,308 | 116.62 USD | |
| 17 Sept 2024 | EXERCISE | Vaxcyte, Inc. | 6,250 | 0.00 USD | deriv |